Search

Mark L. Berch

Examiner (ID: 2144)

Most Active Art Unit
1202
Art Unit(s)
2899, 1802, 1202, 1611, 1622, 1624, 1614
Total Applications
3573
Issued Applications
2301
Pending Applications
170
Abandoned Applications
1103

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6628790 [patent_doc_number] => 20100004236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'PHOSPHODIESTERASE 4 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/393634 [patent_app_country] => US [patent_app_date] => 2009-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26063 [patent_no_of_claims] => 97 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004236.pdf [firstpage_image] =>[orig_patent_app_number] => 12393634 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/393634
PHOSPHODIESTERASE 4 INHIBITORS Feb 25, 2009 Abandoned
Array ( [id] => 5532980 [patent_doc_number] => 20090232768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'NOVEL COMPOUNDS AND METHODS FOR THERAPY' [patent_app_type] => utility [patent_app_number] => 12/388789 [patent_app_country] => US [patent_app_date] => 2009-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24980 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232768.pdf [firstpage_image] =>[orig_patent_app_number] => 12388789 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/388789
Nucleoside analogues containing phosphonate or phosphonamide groups Feb 18, 2009 Issued
Array ( [id] => 5422945 [patent_doc_number] => 20090149400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'ANTI-PROLIFERATIVE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/388295 [patent_app_country] => US [patent_app_date] => 2009-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34441 [patent_no_of_claims] => 130 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20090149400.pdf [firstpage_image] =>[orig_patent_app_number] => 12388295 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/388295
Anti-proliferative compounds, compositions, and methods of use thereof Feb 17, 2009 Issued
Array ( [id] => 8802544 [patent_doc_number] => 08440819 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-14 [patent_title] => 'Therapeutic substituted beta-lactams' [patent_app_type] => utility [patent_app_number] => 12/372417 [patent_app_country] => US [patent_app_date] => 2009-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7232 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12372417 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/372417
Therapeutic substituted beta-lactams Feb 16, 2009 Issued
Array ( [id] => 5540016 [patent_doc_number] => 20090221821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'ADENOSINE RECEPTOR ANTAGONISTS AND METHODS OF MAKING AND USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/368469 [patent_app_country] => US [patent_app_date] => 2009-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 36760 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221821.pdf [firstpage_image] =>[orig_patent_app_number] => 12368469 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/368469
ADENOSINE RECEPTOR ANTAGONISTS AND METHODS OF MAKING AND USING THE SAME Feb 9, 2009 Abandoned
Array ( [id] => 5380337 [patent_doc_number] => 20090192176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => '1H-PYRAZOLO[3,4-D]PYRIMIDINE, PURINE, 7H-PURIN-8(9H)-ONE, 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE, AND THIENO[3,2-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES' [patent_app_type] => utility [patent_app_number] => 12/361607 [patent_app_country] => US [patent_app_date] => 2009-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50223 [patent_no_of_claims] => 104 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20090192176.pdf [firstpage_image] =>[orig_patent_app_number] => 12361607 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/361607
1H-PYRAZOLO[3,4-D]PYRIMIDINE, PURINE, 7H-PURIN-8(9H)-ONE, 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE, AND THIENO[3,2-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES Jan 28, 2009 Abandoned
Array ( [id] => 5575989 [patent_doc_number] => 20090143351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'SUBSTITUTED AZETIDINONES' [patent_app_type] => utility [patent_app_number] => 12/359490 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 136 [patent_figures_cnt] => 136 [patent_no_of_words] => 39616 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143351.pdf [firstpage_image] =>[orig_patent_app_number] => 12359490 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/359490
SUBSTITUTED AZETIDINONES Jan 25, 2009 Abandoned
Array ( [id] => 5279300 [patent_doc_number] => 20090131432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'XANTHINE DERIVATES, THEIR PREPARATION AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/355011 [patent_app_country] => US [patent_app_date] => 2009-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11526 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131432.pdf [firstpage_image] =>[orig_patent_app_number] => 12355011 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/355011
Xanthine derivates, their preparation and their use in pharmaceutical compositions Jan 15, 2009 Issued
Array ( [id] => 7550700 [patent_doc_number] => 08063033 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-22 [patent_title] => 'Therapeutic beta-lactams' [patent_app_type] => utility [patent_app_number] => 12/352903 [patent_app_country] => US [patent_app_date] => 2009-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10373 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/063/08063033.pdf [firstpage_image] =>[orig_patent_app_number] => 12352903 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/352903
Therapeutic beta-lactams Jan 12, 2009 Issued
Array ( [id] => 7535383 [patent_doc_number] => 08049009 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-01 [patent_title] => 'Process for the preparation of Tenofovir' [patent_app_type] => utility [patent_app_number] => 12/352182 [patent_app_country] => US [patent_app_date] => 2009-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3474 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/049/08049009.pdf [firstpage_image] =>[orig_patent_app_number] => 12352182 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/352182
Process for the preparation of Tenofovir Jan 11, 2009 Issued
Array ( [id] => 4540015 [patent_doc_number] => 07875608 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-25 [patent_title] => 'Substituted 8-[6-amino-3pyridyl]xanthines' [patent_app_type] => utility [patent_app_number] => 12/337010 [patent_app_country] => US [patent_app_date] => 2008-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7783 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/875/07875608.pdf [firstpage_image] =>[orig_patent_app_number] => 12337010 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/337010
Substituted 8-[6-amino-3pyridyl]xanthines Dec 16, 2008 Issued
Array ( [id] => 5546721 [patent_doc_number] => 20090156598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Imidazolopyrimidine modulators of TRPV1' [patent_app_type] => utility [patent_app_number] => 12/316827 [patent_app_country] => US [patent_app_date] => 2008-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11146 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156598.pdf [firstpage_image] =>[orig_patent_app_number] => 12316827 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/316827
Imidazolopyrimidine modulators of TRPV1 Dec 15, 2008 Abandoned
Array ( [id] => 8245064 [patent_doc_number] => 08202991 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-19 [patent_title] => 'Process for the preparation of 2-fluoroadenine' [patent_app_type] => utility [patent_app_number] => 12/332723 [patent_app_country] => US [patent_app_date] => 2008-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2533 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 204 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/202/08202991.pdf [firstpage_image] =>[orig_patent_app_number] => 12332723 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/332723
Process for the preparation of 2-fluoroadenine Dec 10, 2008 Issued
Array ( [id] => 5441818 [patent_doc_number] => 20090093457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'XANTHINE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/331720 [patent_app_country] => US [patent_app_date] => 2008-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21053 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093457.pdf [firstpage_image] =>[orig_patent_app_number] => 12331720 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/331720
Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions Dec 9, 2008 Issued
Array ( [id] => 7687308 [patent_doc_number] => 20090176983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Tenofovir Disoproxil Hemi-Fumaric Acid Co-Crystal' [patent_app_type] => utility [patent_app_number] => 12/325525 [patent_app_country] => US [patent_app_date] => 2008-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12512 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176983.pdf [firstpage_image] =>[orig_patent_app_number] => 12325525 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/325525
Tenofovir Disoproxil Hemi-Fumaric Acid Co-Crystal Nov 30, 2008 Abandoned
Array ( [id] => 6002955 [patent_doc_number] => 20110118229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => '2-ARYLMETHYLAZETIDINE-CARBAPENEM-3-CARBOXYLIC ACID ESTER DERIVATIVE OR ITS SALT, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/742966 [patent_app_country] => US [patent_app_date] => 2008-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13226 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118229.pdf [firstpage_image] =>[orig_patent_app_number] => 12742966 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/742966
2-ARYLMETHYLAZETIDINE-CARBAPENEM-3-CARBOXYLIC ACID ESTER DERIVATIVE OR ITS SALT, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Nov 17, 2008 Abandoned
Array ( [id] => 5272494 [patent_doc_number] => 20090076270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Drying process for preparing crystalline solid famciclovir' [patent_app_type] => utility [patent_app_number] => 12/291951 [patent_app_country] => US [patent_app_date] => 2008-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3559 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076270.pdf [firstpage_image] =>[orig_patent_app_number] => 12291951 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/291951
Drying process for preparing crystalline solid famciclovir Nov 13, 2008 Abandoned
Array ( [id] => 4624340 [patent_doc_number] => 08003636 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-23 [patent_title] => 'Certain crystalline diphenylazetidinone hydrates, pharmaceutical compositions thereof and methods for their use' [patent_app_type] => utility [patent_app_number] => 12/269802 [patent_app_country] => US [patent_app_date] => 2008-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11098 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/003/08003636.pdf [firstpage_image] =>[orig_patent_app_number] => 12269802 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/269802
Certain crystalline diphenylazetidinone hydrates, pharmaceutical compositions thereof and methods for their use Nov 11, 2008 Issued
Array ( [id] => 5316477 [patent_doc_number] => 20090281075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'ISOMERIC PURINONES AND 1H-IMIDAZOPYRIDINONES AS PKC-THETA INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/267271 [patent_app_country] => US [patent_app_date] => 2008-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19229 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281075.pdf [firstpage_image] =>[orig_patent_app_number] => 12267271 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/267271
ISOMERIC PURINONES AND 1H-IMIDAZOPYRIDINONES AS PKC-THETA INHIBITORS Nov 6, 2008 Abandoned
Array ( [id] => 5304405 [patent_doc_number] => 20090299057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'MEROPENEM INTERMEDIATE IN NOVEL CRYSTALLINE FORM AND A METHOD OF MANUFACTURE OF MEROPENEM' [patent_app_type] => utility [patent_app_number] => 12/255668 [patent_app_country] => US [patent_app_date] => 2008-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3528 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20090299057.pdf [firstpage_image] =>[orig_patent_app_number] => 12255668 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/255668
Meropenem intermediate in novel crystalline form and a method of manufacture of meropenem Oct 21, 2008 Issued
Menu